Showing results (51-60 of 88) with videos related to
Sort By:
Pageof 9
Brain : a Journal of Neurology|March 5, 2020
In vivo CRISPRa decreases seizures and rescues cognitive deficits in a rodent model of epilepsyGaia Colasante, Yichen Qiu, Luca Massimino, et al.Neuron|September 14, 2019
SETD5 Regulates Chromatin Methylation State and Preserves Global Transcriptional Fidelity during Brain Development and Neuronal WiringAlessandro Sessa, Luca Fagnocchi, Giuseppina Mastrototaro, et al.Cell Reports. Medicine|March 18, 2025
Microbiota-produced immune regulatory bile acid metabolites control central nervous system autoimmunityMartina Antonini Cencicchio, Federico Montini, Vittoria Palmieri, et al.Cell Reports|February 22, 2018
Pharmacological Inhibition of Necroptosis Protects from Dopaminergic Neuronal Cell Death in Parkinson's Disease ModelsAngelo Iannielli, Simone Bido, Lucrezia Folladori, et al.Glia|February 3, 2026
Prostaglandin D2 Synthase Controls Schwann Cells Metabolism and Peripheral Myelin HomeostasisAmelia Trimarco, Matteo Audano, Rosa La Marca, et al.Nature Communications|February 8, 2017
Two factor-based reprogramming of rodent and human fibroblasts into Schwann cellsPietro Giuseppe Mazzara, Luca Massimino, Marta Pellegatta, et al.United European Gastroenterology Journal|August 31, 2024
Inflammatory bowel disease genomics, transcriptomics, proteomics and metagenomics meet artificial intelligenceAnna Lucia Cannarozzi, Anna Latiano, Luca Massimino, et al.Critical Reviews in Oncology/Hematology|March 10, 2025
Artificial intelligence and whole slide imaging, a new tool for the microsatellite instability prediction in colorectal cancer: Friend or foe?Anna Lucia Cannarozzi, Giuseppe Biscaglia, Paola Parente, et al.Nature Communications|July 1, 2021
SETBP1 accumulation induces P53 inhibition and genotoxic stress in neural progenitors underlying neurodegeneration in Schinzel-Giedion syndromeFederica Banfi, Alicia Rubio, Mattia Zaghi, et al.Journal of Crohn'S & Colitis|June 7, 2026
Effectiveness and safety of mirikizumab in patients with moderate-to-severe ulcerative colitis: the miri real multicenter studyFerdinando D'Amico, Fabrizio Fanizzi, Arianna Dal Buono, et al.Pageof 9